TP53 and cancer: Gene set variation analysis (GSVA) for Risk-H and Risk-L groups showed that cancer-related pathways such as cell cycle, P53 signaling pathway, and pathways in cancer had a significantly positive correlation with risk score (Figure 2(g)).